GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,404 | -99.7% | 1,856,194 | +147.5% | 0.36% | +335.4% |
| Q3 2022 | $1,928,000 | +6.2% | 750,000 | 0.0% | 0.08% | -15.5% |
| Q2 2022 | $1,815,000 | -41.3% | 750,000 | 0.0% | 0.10% | -24.8% |
| Q1 2022 | $3,090,000 | -68.0% | 750,000 | 0.0% | 0.13% | -50.8% |
| Q4 2021 | $9,645,000 | +346.7% | 750,000 | +200.0% | 0.26% | +201.1% |
| Q3 2019 | $2,159,000 | -61.2% | 250,000 | -50.0% | 0.09% | -61.3% |
| Q2 2019 | $5,570,000 | +109.4% | 500,000 | +150.0% | 0.22% | +106.4% |
| Q1 2019 | $2,660,000 | -13.9% | 200,000 | 0.0% | 0.11% | -4.4% |
| Q4 2018 | $3,090,000 | +8.5% | 200,000 | 0.0% | 0.11% | +54.1% |
| Q3 2018 | $2,848,000 | – | 200,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |